Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.58 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.36.
Market Cap
9.58T
Revenue
4.66T
Profits
186.59B
PE Ratio
51.36
Profit Margin
4.00%
Dividend Yield
0.37%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -3.59% | 3,006,469 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 650.67B | -1.15% | 7,273,372 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 464.58B | -1.09% | 3,308,443 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 377.72B | -2.14% | 8,727,617 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 359.94B | 1.11% | 3,560,033 | 450.53B |
| 6 | NVS | Novartis AG | 300.07B | -1.53% | 1,473,501 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 257.89B | -2.00% | 2,680,820 | 61.37B |
| 8 | AMGN | Amgen Inc. | 238.06B | -0.43% | 2,289,656 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 234.31B | 0.89% | 1,843,113 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 210.23B | -3.02% | 8,877,893 | 50.34B |
| 11 | ABT | Abbott Laboratories | 197.44B | -1.75% | 6,959,228 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 183.62B | -0.46% | 5,259,080 | 30.46B |
| 13 | PFE | Pfizer Inc. | 161.30B | -0.95% | 35,069,971 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.40B | -0.28% | 2,531,033 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.72B | -1.01% | 834,203 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 138.03B | -0.52% | 7,511,516 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.86B | -0.38% | 1,665,742 | 11.03B |
| 18 | SYK | Stryker Corporation | 126.45B | -0.28% | 1,571,538 | 25.84B |
| 19 | CVS | CVS Health Corporation | 120.63B | 1.53% | 6,162,108 | 412.65B |
| 20 | MDT | Medtronic plc | 117.78B | 0.97% | 6,046,287 | 36.36B |
| 21 | SNY | Sanofi | 109.28B | -1.30% | 1,628,263 | 55.89B |
| 22 | MCK | McKesson Corporation | 104.54B | -0.93% | 1,059,071 | 410.98B |
| 23 | GSK | GSK plc | 103.45B | -1.23% | 1,716,708 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.48B | -0.37% | 1,318,424 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.30B | 0.92% | 683,833 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 81.36B | -2.25% | 585,177 | 15.53B |
| 27 | CI | The Cigna Group | 74.22B | 0.55% | 1,228,295 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.81B | -3.39% | 36,584,801 | 21.00B |
| 29 | ARGX | argenx SE | 65.40B | 2.71% | 361,917 | 5.32B |
| 30 | COR | Cencora, Inc. | 62.55B | -0.08% | 841,573 | 332.77B |
| 31 | MRNA | Moderna, Inc. | 59.75B | -5.77% | 22,009,460 | 2.23B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.71B | -0.65% | 2,331,741 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 55.45B | 0.20% | 1,472,960 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.33B | -0.10% | 2,778,774 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.81B | 0.23% | 1,403,110 | 22.48B |
| 36 | NTRA | Natera, Inc. | 48.79B | 0.52% | 1,093,400 | 2.71B |
| 37 | HUM | Humana Inc. | 46.96B | 0.35% | 908,160 | 145.68B |
| 38 | RVMD | Revolution Medicines, Inc. | 46.18B | 1.92% | 3,524,065 | - |
| 39 | MDLN | Medline Inc. | 45.46B | -2.97% | 7,580,780 | 29.94B |
| 40 | HLN | Haleon plc | 44.69B | -0.10% | 5,398,532 | 14.80B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 44.19B | -0.47% | 4,816,013 | 17.32B |
| 42 | A | Agilent Technologies, Inc. | 43.80B | 0.20% | 3,204,828 | 7.37B |
| 43 | IDXX | IDEXX Laboratories, Inc. | 43.60B | 0.62% | 349,442 | 4.55B |
| 44 | IQV | IQVIA Holdings Inc. | 43.04B | 0.81% | 1,272,087 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 42.73B | -0.15% | 125,831 | 6.13B |
| 46 | WAT | Waters Corporation | 40.69B | -0.07% | 426,639 | 4.64B |
| 47 | VEEV | Veeva Systems Inc. | 39.78B | -0.76% | 1,457,501 | 3.46B |
| 48 | RPRX | Royalty Pharma plc | 35.54B | -0.43% | 1,478,062 | 2.54B |
| 49 | ALC | Alcon Inc. | 35.16B | -0.95% | 772,113 | 10.86B |
| 50 | RMD | ResMed Inc. | 34.00B | -0.38% | 1,542,337 | 5.65B |
| 51 | ILMN | Illumina, Inc. | 33.95B | -0.07% | 1,713,910 | 4.49B |
| 52 | DXCM | DexCom, Inc. | 33.57B | -0.22% | 3,820,095 | 4.97B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 33.11B | -0.81% | 2,043,143 | 21.27B |
| 54 | BIIB | Biogen Inc. | 32.66B | 0.14% | 647,144 | 10.03B |
| 55 | CNC | Centene Corporation | 32.34B | 0.72% | 3,596,817 | 180.30B |
| 56 | ZTS | Zoetis Inc. | 32.03B | 0.30% | 4,847,171 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.98B | -0.45% | 1,116,261 | 4.80B |
| 58 | BNTX | BioNTech SE | 28.28B | -1.31% | 1,254,954 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 28.02B | -0.27% | 97,126 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 27.23B | -0.58% | 701,175 | 14.35B |
| 61 | INSM | Insmed Incorporated | 27.16B | 0.40% | 1,979,878 | 1.14B |
| 62 | DGX | Quest Diagnostics Incorporated | 27.04B | 0.20% | 811,022 | 11.56B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.55B | 0.77% | 5,260,327 | 7.53M |
| 64 | PHG | Koninklijke Philips N.V. | 26.35B | -1.60% | 751,846 | 20.18B |
| 65 | INCY | Incyte Corporation | 25.97B | -1.23% | 800,046 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.63B | 0.41% | 440,221 | 3.33B |
| 67 | STE | STERIS plc | 23.09B | 0.14% | 547,413 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.94B | 3.64% | 2,011,096 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 22.16B | -0.36% | 254,778 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 22.08B | 0.85% | 513,311 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.09B | -1.78% | 3,086,693 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.35B | 0.78% | 7,402,241 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.34B | 1.14% | 1,352,838 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.28B | 0.81% | 148,497 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.43B | -1.08% | 237,263 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.18B | -4.20% | 2,418,903 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.92B | 2.10% | 1,119,183 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.58B | -0.09% | 1,019,466 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 15.52B | -1.28% | 1,704,982 | 713.07M |
| 80 | COO | The Cooper Companies, Inc. | 14.17B | -0.49% | 1,560,118 | 4.23B |
| 81 | RVTY | Revvity, Inc. | 14.10B | 1.21% | 1,155,877 | 2.91B |
| 82 | CRL | Charles River Laboratories International, Inc. | 14.09B | -0.85% | 1,231,097 | 4.00B |
| 83 | EXEL | Exelixis, Inc. | 13.90B | -1.09% | 1,816,687 | 2.44B |
| 84 | BAX | Baxter International Inc. | 13.70B | 0.80% | 5,186,519 | 11.47B |
| 85 | ICLR | ICON Public Limited Company | 13.03B | 0.01% | 413,983 | 8.29B |
| 86 | CORT | Corcept Therapeutics Incorporated | 12.95B | -3.05% | 981,082 | 830.81M |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.78B | 7.20% | 2,552,554 | 14.37B |
| 88 | PEN | Penumbra, Inc. | 12.72B | -0.41% | 513,088 | 1.50B |
| 89 | BMRN | BioMarin Pharmaceutical Inc. | 12.70B | -0.77% | 1,884,303 | 3.41B |
| 90 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.59B | 0.27% | 859,356 | 669.50M |
| 91 | ELAN | Elanco Animal Health Incorporated | 12.53B | -0.04% | 4,153,361 | 5.02B |
| 92 | FMS | Fresenius Medical Care AG | 12.46B | -0.47% | 877,369 | 22.19B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.45B | 5.22% | 345,523 | 1.28B |
| 94 | TEM | Tempus AI, Inc. | 12.36B | -0.36% | 5,225,821 | 1.43B |
| 95 | SNN | Smith & Nephew plc | 12.24B | 0.27% | 2,378,776 | 6.30B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 12.15B | -2.07% | 1,705,555 | 1.66B |
| 97 | EHC | Encompass Health Corporation | 11.92B | 0.53% | 1,679,306 | 6.21B |
| 98 | DVA | DaVita Inc. | 11.48B | 1.27% | 528,810 | 14.01B |
| 99 | SMMT | Summit Therapeutics Inc. | 11.35B | 6.51% | 11,634,709 | - |
| 100 | TECH | Bio-Techne Corporation | 11.35B | 0.07% | 1,386,263 | 1.22B |
| 101 | ALGN | Align Technology, Inc. | 11.31B | -0.29% | 653,655 | 4.14B |
| 102 | GMED | Globus Medical, Inc. | 11.16B | 0.17% | 970,830 | 3.14B |
| 103 | CYTK | Cytokinetics, Incorporated | 11.01B | 2.25% | 1,236,590 | 67.67M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.94B | -1.20% | 511,820 | 5.67M |
| 105 | AXSM | Axsome Therapeutics, Inc. | 10.85B | 0.81% | 378,909 | 776.57M |
| 106 | KRYS | Krystal Biotech, Inc. | 10.65B | 1.00% | 281,023 | 440.48M |
| 107 | GKOS | Glaukos Corporation | 10.65B | -0.45% | 506,040 | 612.84M |
| 108 | MOH | Molina Healthcare, Inc. | 10.54B | 1.40% | 413,515 | 42.47B |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 10.54B | 2.54% | 480,526 | 7.46M |
| 110 | UHS | Universal Health Services, Inc. | 10.53B | 1.67% | 632,826 | 18.11B |
| 111 | IONS | Ionis Pharmaceuticals, Inc. | 10.53B | -0.33% | 2,152,849 | 874.09M |
| 112 | KYMR | Kymera Therapeutics, Inc. | 10.44B | -0.86% | 558,342 | 105.00M |
| 113 | ENSG | The Ensign Group, Inc. | 10.44B | 0.90% | 237,241 | 5.49B |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 10.39B | -0.44% | 221,655 | 2.59B |
| 115 | RDY | Dr. Reddy's Laboratories Limited | 10.36B | -0.97% | 1,674,681 | 3.50B |
| 116 | APGE | Apogee Therapeutics, Inc. | 10.18B | 0.07% | 1,613,316 | - |
| 117 | RGEN | Repligen Corporation | 10.18B | -0.77% | 539,037 | 785.10M |
| 118 | HSIC | Henry Schein, Inc. | 10.07B | 0.81% | 697,159 | 13.60B |
| 119 | PODD | Insulet Corporation | 9.94B | 0.23% | 1,423,967 | 3.05B |
| 120 | AVTR | Avantor, Inc. | 9.81B | 0.55% | 4,772,316 | 6.56B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.80B | 0.60% | 335,461 | 281.99M |
| 122 | OSCR | Oscar Health, Inc. | 9.63B | 1.00% | 3,400,292 | 15.32B |
| 123 | TWST | Twist Bioscience Corporation | 9.41B | -0.90% | 1,213,065 | 431.80M |
| 124 | PCVX | Vaxcyte, Inc. | 9.09B | - | 891,648 | - |
| 125 | IMVT | Immunovant, Inc. | 9.07B | 0.90% | 852,423 | - |
| 126 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | -0.02% | 479,512 | 42.16M |
| 127 | QGEN | Qiagen N.V. | 8.97B | -0.66% | 1,538,368 | 2.10B |
| 128 | IBRX | ImmunityBio, Inc. | 8.74B | 0.73% | 9,446,459 | 165.79M |
| 129 | HQY | HealthEquity, Inc. | 8.73B | -0.92% | 774,507 | 1.34B |
| 130 | BRKR | Bruker Corporation | 8.69B | 0.37% | 2,528,373 | 3.50B |
| 131 | ATR | AptarGroup, Inc. | 8.60B | 0.39% | 281,376 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.37B | -0.71% | 3,079,120 | 616.91M |
| 133 | SYRE | Spyre Therapeutics, Inc. | 8.25B | -12.81% | 3,115,150 | - |
| 134 | ALKS | Alkermes plc | 8.25B | -0.10% | 660,875 | 1.67B |
| 135 | TGTX | TG Therapeutics, Inc. | 7.81B | -0.70% | 963,164 | 799.54M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.70B | -1.31% | 358,951 | 239.92M |
| 137 | CAI | Caris Life Sciences, Inc. | 7.58B | -4.25% | 4,028,890 | 989.61M |
| 138 | SRRK | Scholar Rock Holding Corporation | 7.31B | 3.07% | 2,281,282 | - |
| 139 | HNGE | Hinge Health, Inc. | 7.30B | 0.70% | 1,975,327 | 720.06M |
| 140 | CHE | Chemed Corporation | 7.14B | 0.84% | 128,651 | 2.60B |
| 141 | PACS | PACS Group, Inc. | 7.03B | 1.02% | 363,878 | 5.55B |
| 142 | GRFS | Grifols, S.A. | 7.01B | -2.35% | 465,283 | 8.48B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.96B | -6.05% | 11,584,144 | 2.58B |
| 144 | CGON | CG Oncology, Inc. | 6.95B | -0.67% | 507,809 | 6.23M |
| 145 | ERAS | Erasca, Inc. | 6.70B | 7.83% | 7,691,169 | - |
| 146 | ORKA | Oruka Therapeutics, Inc. | 6.58B | -2.34% | 526,711 | - |
| 147 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.05% | 1,315,876 | 1.56B |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 6.40B | 0.44% | 571,055 | 618.07M |
| 149 | LQDA | Liquidia Corporation | 6.39B | 1.23% | 846,005 | 450.91M |
| 150 | COGT | Cogent Biosciences, Inc. | 6.37B | -0.22% | 1,062,731 | - |
| 151 | TVTX | Travere Therapeutics, Inc. | 6.33B | 0.16% | 1,215,050 | 591.33M |
| 152 | BLTE | Belite Bio, Inc | 6.31B | -3.09% | 269,759 | - |
| 153 | AMRX | Amneal Pharmaceuticals, Inc. | 6.27B | 0.39% | 1,205,164 | 3.12B |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 6.20B | -1.20% | 335,358 | 1.90M |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 6.18B | 5.58% | 1,295,950 | 7.50M |
| 156 | BLCO | Bausch + Lomb Corporation | 6.16B | - | 350,897 | 5.32B |
| 157 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.14B | -1.90% | 383,791 | 840.85M |
| 158 | STVN | Stevanato Group S.p.A. | 6.11B | -1.41% | 499,243 | 1.40B |
| 159 | PTCT | PTC Therapeutics, Inc. | 6.07B | -1.06% | 533,615 | 1.01B |
| 160 | RDNT | RadNet, Inc. | 6.02B | -0.51% | 390,610 | 2.27B |
| 161 | DFTX | Definium Therapeutics, Inc. | 5.88B | -2.32% | 1,599,043 | - |
| 162 | TFX | Teleflex Incorporated | 5.88B | -1.03% | 533,767 | 2.25B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | 2.18% | 147,461 | 290.54M |
| 164 | CRSP | CRISPR Therapeutics AG | 5.73B | -2.74% | 959,809 | 13.39M |
| 165 | SHC | Sotera Health Company | 5.58B | 0.15% | 1,908,967 | 1.22B |
| 166 | MMED | MiniMed Group, Inc. | 5.47B | 3.01% | 1,244,730 | 3.10B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.41B | -0.60% | 544,267 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.10B | -3.24% | 1,336,140 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.92B | 0.08% | 1,402,821 | - |
| 170 | HAE | Haemonetics Corporation | 4.85B | -1.59% | 661,278 | 1.35B |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.85B | 0.08% | 409,252 | 148.00K |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.82B | 0.38% | 814,071 | - |
| 173 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.65B | -1.01% | 2,815,491 | -665.00K |
| 174 | CELC | Celcuity Inc. | 4.65B | 3.05% | 655,356 | - |
| 175 | LFST | LifeStance Health Group, Inc. | 4.64B | -1.06% | 4,432,476 | 1.58B |
| 176 | WAY | Waystar Holding Corp. | 4.63B | -0.17% | 2,794,957 | 1.21B |
| 177 | BLLN | BillionToOne, Inc. | 4.54B | -3.86% | 505,506 | 397.41M |
| 178 | ICUI | ICU Medical, Inc. | 4.49B | -1.45% | 161,550 | 2.16B |
| 179 | NVST | Envista Holdings Corporation | 4.47B | 1.20% | 1,524,896 | 2.86B |
| 180 | ELVN | Enliven Therapeutics, Inc. | 4.46B | -0.24% | 971,127 | - |
| 181 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | 0.49% | 683,956 | 2.29B |
| 182 | DOCS | Doximity, Inc. | 4.41B | - | 1,889,959 | 655.57M |
| 183 | LIVN | LivaNova PLC | 4.41B | 0.71% | 733,421 | 1.47B |
| 184 | MANE | Veradermics, Incorporated | 4.29B | 0.44% | 657,047 | - |
| 185 | TNGX | Tango Therapeutics, Inc. | 4.29B | 2.83% | 3,174,406 | 53.81M |
| 186 | RLAY | Relay Therapeutics, Inc. | 4.26B | -5.40% | 2,936,555 | 10.35M |
| 187 | HTFL | HeartFlow, Inc. | 4.26B | -1.90% | 1,653,688 | 212.07M |
| 188 | ITGR | Integer Holdings Corporation | 4.26B | -0.16% | 456,640 | 1.84B |
| 189 | INDV | Indivior Pharmaceuticals, Inc. | 4.23B | -0.40% | 1,275,337 | 1.33B |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 4.18B | -0.34% | 1,387,254 | 308.08M |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 4.01B | -2.12% | 724,889 | 234.13M |
| 192 | VKTX | Viking Therapeutics, Inc. | 4.01B | 0.61% | 1,144,995 | - |
| 193 | LEGN | Legend Biotech Corporation | 4.01B | -2.91% | 924,972 | 1.27B |
| 194 | ABCL | AbCellera Biologics Inc. | 3.97B | -2.08% | 5,035,544 | 66.17M |
| 195 | IRTC | iRhythm Holdings, Inc. | 3.93B | -3.20% | 467,746 | 825.34M |
| 196 | DNLI | Denali Therapeutics Inc. | 3.93B | -1.44% | 771,232 | 3.60M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.92B | -2.57% | 685,581 | 117.00M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.77B | -4.79% | 123,256 | 890.79M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.66B | -4.27% | 10,102,348 | 324.97M |
| 200 | OGN | Organon & Co. | 3.62B | 0.15% | 4,153,509 | 6.13B |
| 201 | OPCH | Option Care Health, Inc. | 3.60B | 1.69% | 1,410,339 | 5.69B |
| 202 | VCYT | Veracyte, Inc. | 3.56B | 0.57% | 2,181,424 | 561.90M |
| 203 | GRAL | GRAIL, Inc. | 3.55B | -3.57% | 396,852 | 165.26M |
| 204 | QURE | uniQure N.V. | 3.53B | -0.20% | 900,701 | 18.67M |
| 205 | NHC | National HealthCare Corporation | 3.53B | 0.16% | 89,453 | 1.56B |
| 206 | GPCR | Structure Therapeutics Inc. | 3.52B | -1.14% | 937,153 | - |
| 207 | PLSE | Pulse Biosciences, Inc. | 3.43B | -1.84% | 270,307 | 1.19M |
| 208 | NAMS | NewAmsterdam Pharma Company N.V. | 3.28B | 0.22% | 758,705 | 7.12M |
| 209 | IMNM | Immunome, Inc. | 3.27B | -2.18% | 559,028 | 4.02M |
| 210 | MBX | MBX Biosciences, Inc. | 3.22B | -2.71% | 214,624 | - |
| 211 | TMDX | TransMedics Group, Inc. | 3.20B | -1.47% | 448,743 | 668.47M |
| 212 | CLDX | Celldex Therapeutics, Inc. | 3.19B | -1.58% | 540,650 | 158.00K |
| 213 | IRON | Disc Medicine, Inc. | 3.17B | 0.32% | 556,890 | - |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | 1.13% | 1,911,323 | 463.98M |
| 215 | WRBY | Warby Parker Inc. | 3.15B | -2.00% | 1,678,861 | 911.61M |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 3.10B | -1.12% | 611,549 | 606.33M |
| 217 | ALMS | Alumis Inc. | 3.06B | -1.42% | 642,629 | 7.40M |
| 218 | BEAM | Beam Therapeutics Inc. | 3.02B | -2.71% | 1,392,064 | 156.04M |
| 219 | AVAH | Aveanna Healthcare Holdings Inc. | 2.97B | 0.22% | 2,509,376 | 2.60B |
| 220 | ZLAB | Zai Lab Limited | 2.92B | -0.53% | 1,140,885 | 449.61M |
| 221 | BKD | Brookdale Senior Living Inc. | 2.91B | - | 2,901,771 | 2.93B |
| 222 | ALHC | Alignment Healthcare, Inc. | 2.88B | 2.28% | 7,243,647 | 4.58B |
| 223 | ACHC | Acadia Healthcare Company, Inc. | 2.85B | 2.38% | 2,028,986 | 3.37B |
| 224 | AXGN | Axogen, Inc. | 2.77B | 3.30% | 848,626 | 251.17M |
| 225 | SLS | SELLAS Life Sciences Group, Inc. | 2.77B | -2.56% | 4,593,612 | - |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.77B | -0.89% | 551,874 | 36.77M |
| 227 | VRDN | Viridian Therapeutics, Inc. | 2.75B | 0.33% | 780,742 | 71.13M |
| 228 | ATAI | AtaiBeckley Inc. | 2.74B | -0.67% | 3,740,380 | 4.47M |
| 229 | RGC | Regencell Bioscience Holdings Limited | 2.73B | -0.72% | 61,579 | - |
| 230 | WGS | GeneDx Holdings Corp. | 2.69B | 3.29% | 430,276 | 454.43M |
| 231 | PRVA | Privia Health Group, Inc. | 2.69B | -0.61% | 724,816 | 2.36B |
| 232 | PGEN | Precigen, Inc. | 2.66B | 1.92% | 7,409,473 | 85.72M |
| 233 | VERA | Vera Therapeutics, Inc. | 2.65B | 4.37% | 2,378,134 | - |
| 234 | CDNA | CareDx, Inc. | 2.64B | 0.31% | 1,415,704 | 458.09M |
| 235 | SUPN | Supernus Pharmaceuticals, Inc. | 2.61B | -1.06% | 499,683 | 830.44M |
| 236 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | -0.08% | 1,667,810 | 717.00M |
| 237 | PHVS | Pharvaris N.V. | 2.60B | -0.62% | 448,879 | - |
| 238 | BHVN | Biohaven Ltd. | 2.56B | 17.87% | 15,767,953 | - |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.55B | -0.17% | 1,207,760 | - |
| 240 | NEOG | Neogen Corporation | 2.55B | 0.52% | 1,415,605 | 870.40M |
| 241 | RAPP | Rapport Therapeutics, Inc. | 2.52B | 2.60% | 275,088 | 20.00M |
| 242 | NKTR | Nektar Therapeutics | 2.52B | -1.59% | 450,245 | 54.59M |
| 243 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.51B | - | 1,858,863 | 940.61M |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.47B | 1.36% | 365,626 | 1.10B |
| 245 | KOD | Kodiak Sciences Inc. | 2.47B | -0.33% | 296,779 | - |
| 246 | ATRC | AtriCure, Inc. | 2.45B | -1.05% | 859,640 | 569.62M |
| 247 | NUVB | Nuvation Bio Inc. | 2.44B | -1.97% | 3,441,013 | 169.90M |
| 248 | BHC | Bausch Health Companies Inc. | 2.43B | -3.27% | 2,142,377 | 10.85B |
| 249 | KLRA | Kailera Therapeutics, Inc. | 2.39B | 3.89% | 785,292 | - |
| 250 | GRDN | Guardian Pharmacy Services, Inc. | 2.37B | 0.48% | 284,560 | 1.46B |
| 251 | OCUL | Ocular Therapeutix, Inc. | 2.37B | -1.01% | 1,368,107 | 52.06M |
| 252 | ALMR | Alamar Biosciences, Inc. | 2.36B | 3.21% | 551,577 | 100.42M |
| 253 | UFPT | UFP Technologies, Inc. | 2.36B | 0.12% | 163,633 | 631.64M |
| 254 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.31B | -1.11% | 5,538,702 | 208.78M |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 2.31B | 1.82% | 745,185 | 959.90M |
| 256 | BFLY | Butterfly Network, Inc. | 2.30B | -4.42% | 3,904,619 | 112.14M |
| 257 | COAG | Hemab Therapeutics Holdings, Inc. | 2.30B | -0.93% | 334,192 | - |
| 258 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | -1.71% | 766,384 | - |
| 259 | CLOV | Clover Health Investments, Corp. | 2.26B | 2.91% | 3,200,068 | 2.48B |
| 260 | URGN | UroGen Pharma Ltd. | 2.25B | -0.91% | 620,205 | 188.73M |
| 261 | NEO | NeoGenomics, Inc. | 2.23B | 3.45% | 1,682,451 | 766.30M |
| 262 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 4.11% | 194,222 | - |
| 263 | ADUS | Addus HomeCare Corporation | 2.21B | -0.31% | 153,598 | 1.48B |
| 264 | TRLV | Trulieve Cannabis Corp. | 2.20B | 0.97% | 1,630,532 | 1.14B |
| 265 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -1.25% | 777,918 | 311.51M |
| 266 | MESO | Mesoblast Limited | 2.20B | -2.04% | 108,391 | 65.38M |
| 267 | XRAY | DENTSPLY SIRONA Inc. | 2.18B | -0.36% | 2,882,807 | 3.64B |
| 268 | VCEL | Vericel Corporation | 2.17B | -1.80% | 313,605 | 306.30M |
| 269 | HCM | HUTCHMED (China) Limited | 2.16B | 0.73% | 62,746 | 549.12M |
| 270 | ESTA | Establishment Labs Holdings Inc. | 2.16B | 0.42% | 281,636 | 245.82M |
| 271 | ADMA | ADMA Biologics, Inc. | 2.16B | -0.93% | 1,371,358 | 512.28M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 2.15B | -2.16% | 651,481 | 1.00M |
| 273 | MD | Pediatrix Medical Group, Inc. | 2.14B | -0.15% | 528,157 | 1.95B |
| 274 | STOK | Stoke Therapeutics, Inc. | 2.14B | -1.11% | 1,155,275 | 27.59M |
| 275 | XNCR | Xencor, Inc. | 2.11B | -2.94% | 2,121,282 | 104.97M |
| 276 | NVCR | NovoCure Limited | 2.08B | 1.53% | 1,270,857 | 699.19M |
| 277 | ZYME | Zymeworks Inc. | 2.08B | 6.68% | 1,214,908 | 37.13M |
| 278 | GENB | Generate Biomedicines, Inc. | 2.07B | -20.80% | 3,850,038 | 26.48M |
| 279 | SRPT | Sarepta Therapeutics, Inc. | 2.06B | 2.85% | 2,409,796 | 1.97B |
| 280 | PRGO | Perrigo Company plc | 2.05B | 1.93% | 2,602,662 | 4.14B |
| 281 | NBTX | Nanobiotix S.A. | 2.05B | 7.20% | 240,405 | 38.27M |
| 282 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | 0.27% | 812,040 | 98.34M |
| 283 | PGNY | Progyny, Inc. | 2.02B | 2.13% | 1,117,305 | 1.31B |
| 284 | CMPS | COMPASS Pathways plc | 2.02B | -1.81% | 1,744,695 | - |
| 285 | GHRS | GH Research PLC | 1.99B | 0.31% | 145,071 | - |
| 286 | KARD | Kardigan, Inc. | 1.98B | 1.24% | 214,305 | - |
| 287 | ASTH | Astrana Health, Inc. | 1.98B | 2.66% | 281,127 | 3.84B |
| 288 | TSHA | Taysha Gene Therapies, Inc. | 1.96B | -2.90% | 1,280,745 | 5.49M |
| 289 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.03% | 1,392,430 | - |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.91B | -1.82% | 172,513 | 1.13B |
| 291 | IMCR | Immunocore Holdings plc | 1.91B | -0.75% | 255,279 | 430.78M |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.88B | -3.17% | 405,733 | 481.07M |
| 293 | SEPN | Septerna, Inc. | 1.88B | -2.54% | 168,176 | 98.88M |
| 294 | DMRA | Damora Therapeutics, Inc. | 1.88B | -0.75% | 185,906 | - |
| 295 | VIR | Vir Biotechnology, Inc. | 1.87B | 3.45% | 2,248,493 | 303.23M |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | -1.97% | 12,978,424 | 54.86M |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.85B | -2.37% | 2,707,160 | 59.51M |
| 298 | INBX | Inhibrx Biosciences, Inc. | 1.84B | 2.13% | 302,757 | 1.30M |
| 299 | PSNL | Personalis, Inc. | 1.82B | -0.99% | 2,175,004 | 69.67M |
| 300 | SGRY | Surgery Partners, Inc. | 1.82B | -0.07% | 3,297,455 | 3.37B |
| 301 | LMAT | LeMaitre Vascular, Inc. | 1.82B | 0.81% | 150,414 | 262.43M |
| 302 | BLFS | BioLife Solutions, Inc. | 1.81B | -0.59% | 815,982 | 106.69M |
| 303 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 0.85% | 789,966 | 252.25M |
| 304 | ETON | Eton Pharmaceuticals, Inc. | 1.79B | -0.68% | 443,500 | 105.60M |
| 305 | INSP | Inspire Medical Systems, Inc. | 1.79B | 1.20% | 327,235 | 898.74M |
| 306 | BRVE | Braveheart Bio, Inc. | 1.78B | 0.43% | 215,203 | - |
| 307 | FTRE | Fortrea Holdings Inc. | 1.76B | 1.42% | 598,294 | 2.68B |
| 308 | ALVO | Alvotech | 1.75B | -2.77% | 890,178 | 494.61M |
| 309 | ANAB | AnaptysBio, Inc. | 1.72B | -0.63% | 210,234 | 232.39M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.64B | -2.76% | 229,997 | 20.00M |
| 311 | AVLN | Avalyn Pharma Inc. | 1.64B | -3.04% | 142,600 | - |
| 312 | APMD | Apnimed, Inc. | 1.64B | 8.07% | 333,988 | 120.15M |
| 313 | BCAX | Bicara Therapeutics Inc. | 1.64B | 0.61% | 423,819 | - |
| 314 | AGL | agilon health, inc. | 1.61B | -0.38% | 155,782 | 5.92B |
| 315 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | -1.44% | 411,903 | 978.38M |
| 316 | ARDT | Ardent Health, Inc. | 1.58B | -0.62% | 385,192 | 6.41B |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.58B | -0.69% | 1,504,242 | 335.41M |
| 318 | ABSI | Absci Corporation | 1.58B | -4.26% | 2,677,425 | 1.56M |
| 319 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | -2.04% | 561,658 | - |
| 320 | HCSG | Healthcare Services Group, Inc. | 1.57B | -0.13% | 485,199 | 1.86B |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.56B | -1.76% | 286,831 | - |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.56B | -1.30% | 210,638 | 95.13M |
| 323 | LBRX | LB Pharmaceuticals Inc | 1.55B | -1.30% | 244,899 | - |
| 324 | AAPG | Ascentage Pharma Group International | 1.55B | 0.66% | 4,863 | 94.61M |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.54B | -0.67% | 433,837 | - |
| 326 | INVA | Innoviva, Inc. | 1.53B | 0.33% | 693,028 | 440.00M |
| 327 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | 6.91% | 137,934 | - |
| 328 | OMCL | Omnicell, Inc. | 1.53B | 0.69% | 627,168 | 1.25B |
| 329 | NVAX | Novavax, Inc. | 1.52B | -2.44% | 3,514,518 | 413.80M |
| 330 | FRNM | Freenome, Inc. | 1.51B | 0.71% | 500,373 | 35.41M |
| 331 | CNMD | CONMED Corporation | 1.51B | -1.27% | 188,244 | 1.37B |
| 332 | INNV | InnovAge Holding Corp. | 1.50B | 1.10% | 143,345 | 949.17M |
| 333 | REPL | Replimune Group, Inc. | 1.50B | 0.51% | 2,375,262 | - |
| 334 | SPTX | Seaport Therapeutics, Inc. | 1.49B | 12.36% | 135,680 | - |
| 335 | TNDM | Tandem Diabetes Care, Inc. | 1.49B | -0.97% | 1,117,632 | 1.04B |
| 336 | SLBT | SL Science Holding Limited | 1.48B | -1.52% | 20,253 | 3.27M |
| 337 | AKTS | Aktis Oncology, Inc. | 1.47B | -0.67% | 257,124 | 10.06M |
| 338 | HROW | Harrow, Inc. | 1.47B | -4.84% | 566,835 | 275.59M |
| 339 | AZTA | Azenta, Inc. | 1.47B | 1.08% | 602,530 | 613.81M |
| 340 | CGEM | Cullinan Therapeutics, Inc. | 1.47B | -0.44% | 683,292 | - |
| 341 | OMDA | Omada Health, Inc. | 1.47B | 0.08% | 439,597 | 309.76M |
| 342 | PAHC | Phibro Animal Health Corporation | 1.46B | 0.45% | 300,357 | 1.52B |
| 343 | SDGR | Schrödinger, Inc. | 1.46B | -2.60% | 752,125 | 259.04M |
| 344 | ENOV | Enovis Corporation | 1.46B | -1.29% | 553,558 | 2.30B |
| 345 | ATEC | Alphatec Holdings, Inc. | 1.45B | 0.96% | 1,418,757 | 815.05M |
| 346 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | 0.58% | 1,123,726 | - |
| 347 | ANRO | Alto Neuroscience, Inc. | 1.43B | 0.61% | 282,847 | - |
| 348 | SVRA | Savara Inc. | 1.43B | 0.18% | 1,529,744 | - |
| 349 | VOR | Vor Biopharma Inc. | 1.40B | -1.42% | 448,004 | - |
| 350 | MGTX | MeiraGTx Holdings plc | 1.40B | -2.41% | 606,281 | 397.50M |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.38B | 1.77% | 436,743 | - |
| 352 | JBIO | Jade Biosciences, Inc. | 1.36B | -2.34% | 355,912 | - |
| 353 | NUTX | Nutex Health Inc. | 1.34B | 4.16% | 182,161 | 846.72M |
| 354 | PNTG | The Pennant Group, Inc. | 1.34B | 0.08% | 178,100 | 1.10B |
| 355 | MLTX | MoonLake Immunotherapeutics | 1.33B | 0.39% | 1,001,603 | - |
| 356 | AORT | Artivion, Inc. | 1.33B | 3.11% | 609,016 | 471.47M |
| 357 | AMN | AMN Healthcare Services, Inc. | 1.33B | 0.97% | 886,039 | 3.43B |
| 358 | OMER | Omeros Corporation | 1.32B | -5.50% | 1,408,541 | 38.42M |
| 359 | MNKD | MannKind Corporation | 1.32B | -1.68% | 1,766,297 | 393.63M |
| 360 | CRON | Cronos Group Inc. | 1.31B | 1.14% | 1,421,194 | 179.09M |
| 361 | IART | Integra LifeSciences Holdings Corporation | 1.31B | 0.54% | 489,356 | 1.65B |
| 362 | IMTX | Immatics N.V. | 1.29B | 2.06% | 777,952 | 47.65M |
| 363 | CERT | Certara, Inc. | 1.25B | 0.98% | 1,149,791 | 421.75M |
| 364 | SANA | Sana Biotechnology, Inc. | 1.25B | 1.46% | 2,293,554 | - |
| 365 | GDRX | GoodRx Holdings, Inc. | 1.25B | 5.04% | 3,535,620 | 785.23M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 1.17% | 692,813 | - |
| 367 | ODTX | Odyssey Therapeutics, Inc. | 1.23B | -2.33% | 235,722 | 99.00K |
| 368 | GLUE | Monte Rosa Therapeutics, Inc. | 1.23B | -1.24% | 997,709 | 28.73M |
| 369 | PRCT | PROCEPT BioRobotics Corporation | 1.21B | -2.45% | 770,285 | 337.34M |
| 370 | BVS | Bioventus Inc. | 1.17B | -0.78% | 488,878 | 581.85M |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 1.23% | 192,127 | 804.27M |
| 372 | KURA | Kura Oncology, Inc. | 1.16B | -3.90% | 2,704,840 | 77.23M |
| 373 | JANX | Janux Therapeutics, Inc. | 1.15B | 1.12% | 523,779 | 24.00M |
| 374 | TDOC | Teladoc Health, Inc. | 1.15B | 2.26% | 3,086,285 | 2.49B |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 1.15B | -0.91% | 218,813 | 1.04B |
| 376 | STAA | STAAR Surgical Company | 1.15B | -1.38% | 427,931 | 339.59M |
| 377 | IVA | Inventiva S.A. | 1.14B | 2.77% | 924,331 | 7.94M |
| 378 | OPK | OPKO Health, Inc. | 1.13B | 1.34% | 2,890,992 | 587.90M |
| 379 | IRMD | IRADIMED CORPORATION | 1.12B | -0.46% | 87,696 | 86.34M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.10B | 4.10% | 813,986 | 59.00K |
| 381 | SLDB | Solid Biosciences Inc. | 1.04B | -1.72% | 594,133 | - |
| 382 | CSTL | Castle Biosciences, Inc. | 1.04B | -2.63% | 456,261 | 357.28M |
| 383 | PCRX | Pacira BioSciences, Inc. | 1.03B | 1.45% | 505,975 | 746.16M |
| 384 | WVE | Wave Life Sciences, Inc. | 1.03B | -0.38% | 2,197,209 | 65.37M |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -1.28% | 1,200,274 | 41.47M |
| 386 | ABUS | Arbutus Biopharma Corporation | 1.03B | -0.19% | 4,596,779 | 181.72M |
| 387 | QDEL | QuidelOrtho Corporation | 1.02B | -0.93% | 1,598,991 | 2.67B |
| 388 | CADL | Candel Therapeutics, Inc. | 1.02B | -2.35% | 977,968 | - |
| 389 | IMMX | Immix Biopharma, Inc. | 1.01B | -2.76% | 1,385,446 | - |
| 390 | GMRS | GMR Solutions Inc. | 996.39M | 0.94% | 338,953 | 5.88B |
| 391 | HELP | Cybin Inc. | 995.81M | -2.57% | 1,559,903 | - |
| 392 | GERN | Geron Corporation | 982.98M | -1.29% | 9,123,587 | 204.56M |
| 393 | GLAS | Glass House Brands Inc. | 980.12M | 2.67% | 425,164 | 176.98M |
| 394 | DSGN | Design Therapeutics, Inc. | 975.65M | -0.57% | 718,671 | - |
| 395 | ANL | Adlai Nortye Ltd. | 969.83M | 9.61% | 149,688 | 18.06M |
| 396 | ARDX | Ardelyx, Inc. | 954.39M | 1.32% | 2,916,874 | 450.89M |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 949.35M | -0.55% | 472,336 | - |
| 398 | ANNX | Annexon, Inc. | 946.00M | -3.11% | 2,275,670 | - |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 936.69M | 0.18% | 395,566 | 730.02M |
| 400 | CLYM | Climb Bio, Inc. | 923.57M | -9.87% | 1,392,867 | - |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 911.16M | -5.35% | 1,736,052 | 8.22M |
| 402 | CBLL | CeriBell, Inc. | 899.97M | -2.09% | 225,581 | 101.96M |
| 403 | COLL | Collegium Pharmaceutical, Inc. | 895.60M | 0.15% | 613,193 | 808.21M |
| 404 | SGP | SpyGlass Pharma, Inc. | 891.05M | 0.15% | 74,461 | - |
| 405 | TBPH | Theravance Biopharma, Inc. | 884.18M | - | 190,120 | 104.31M |
| 406 | AVR | Anteris Technologies Global Corp. | 872.25M | 0.67% | 558,838 | 2.24M |
| 407 | SIBN | SI-BONE, Inc. | 870.82M | -0.56% | 600,962 | 213.60M |
| 408 | BBNX | Beta Bionics, Inc. | 870.10M | - | 529,896 | 119.01M |
| 409 | RIGL | Rigel Pharmaceuticals, Inc. | 868.24M | -0.58% | 232,249 | 276.79M |
| 410 | FDMT | 4D Molecular Therapeutics, Inc. | 859.60M | -1.02% | 717,881 | 92.01M |
| 411 | INMD | InMode Ltd. | 858.19M | -0.67% | 319,090 | 374.63M |
| 412 | FTH | Faeth Therapeutics, Inc. | 851.96M | -4.49% | 140,919 | - |
| 413 | ACHV | Achieve Life Sciences, Inc. | 851.00M | 1.22% | 1,322,472 | - |
| 414 | AHG | Akso Health Group | 848.14M | 0.59% | 3,163 | 13.83M |
| 415 | DBVT | DBV Technologies S.A. | 848.13M | -3.01% | 242,524 | 5.04M |
| 416 | ATTO | Attovia Therapeutics, Inc. | 841.22M | 0.47% | 143,297 | 1.35M |
| 417 | HSTM | HealthStream, Inc. | 840.94M | -0.38% | 147,317 | 321.12M |
| 418 | PHAR | Pharming Group N.V. | 829.58M | 1.53% | 35,539 | 366.48M |
| 419 | SLN | Silence Therapeutics plc | 814.63M | -1.02% | 301,696 | 615.00K |
| 420 | NVCT | Nuvectis Pharma, Inc. | 814.54M | -3.44% | 362,380 | - |
| 421 | AURA | Aura Biosciences, Inc. | 801.64M | -1.15% | 557,594 | - |
| 422 | OCS | Oculis Holding AG | 800.66M | 0.08% | 161,146 | 1.45M |
| 423 | OBX | Obsidian Therapeutics, Inc. | 797.20M | -3.16% | 118,358 | - |
| 424 | STTK | Shattuck Labs, Inc. | 792.87M | -1.99% | 581,831 | 1.00M |
| 425 | VREX | Varex Imaging Corporation | 778.89M | -0.11% | 552,754 | 865.00M |
| 426 | CBIO | Crescent Biopharma, Inc. | 771.28M | 6.00% | 317,533 | 11.88M |
| 427 | NGNE | Neurogene Inc. | 768.64M | -5.95% | 180,118 | 925.00K |
| 428 | MNPR | Monopar Therapeutics Inc. | 763.31M | 2.62% | 123,663 | - |
| 429 | DRUG | Bright Minds Biosciences Inc. | 760.37M | -3.60% | 70,553 | - |
| 430 | AHCO | AdaptHealth Corp. | 756.43M | 3.47% | 2,255,309 | 3.36B |
| 431 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 742.41M | -1.17% | 247,132 | - |
| 432 | SOPH | SOPHiA GENETICS SA | 726.14M | -1.39% | 231,946 | 86.17M |
| 433 | CTMX | CytomX Therapeutics, Inc. | 723.43M | -1.48% | 2,216,277 | 18.30M |
| 434 | ASMB | Assembly Biosciences, Inc. | 721.17M | 0.25% | 171,431 | 74.85M |
| 435 | PHR | Phreesia, Inc. | 717.02M | 0.69% | 585,295 | 495.59M |
| 436 | SSII | SS Innovations International, Inc. | 715.38M | 0.56% | 21,438 | 52.40M |
| 437 | MPLT | MapLight Therapeutics, Inc. | 714.70M | 2.55% | 909,953 | - |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 708.88M | -2.28% | 1,029,096 | 389.32M |
| 439 | GYRE | Gyre Therapeutics, Inc. | 705.12M | -0.45% | 38,753 | 109.82M |
| 440 | ALLO | Allogene Therapeutics, Inc. | 704.80M | -5.99% | 5,020,715 | 4.64M |
| 441 | AGMB | AgomAb Therapeutics NV | 703.26M | 1.85% | 243,636 | - |
| 442 | TECX | Tectonic Therapeutic, Inc. | 703.19M | -4.61% | 145,120 | - |
| 443 | OABI | OmniAb, Inc. | 699.33M | 3.22% | 1,440,726 | 38.46M |
| 444 | ZVRA | Zevra Therapeutics, Inc. | 697.17M | -2.49% | 555,407 | 136.07M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 696.60M | -0.34% | 800,559 | 239.66M |
| 446 | EVO | Evotec SE | 694.60M | 3.17% | 31,076 | 819.47M |
| 447 | AQST | Aquestive Therapeutics, Inc. | 676.51M | 6.10% | 3,412,030 | 54.09M |
| 448 | PRLD | Prelude Therapeutics Incorporated | 675.65M | -0.46% | 466,282 | 22.42M |
| 449 | SGMT | Sagimet Biosciences Inc. | 675.04M | 5.54% | 1,236,901 | - |
| 450 | VSTM | Verastem, Inc. | 669.26M | 4.38% | 1,681,932 | 87.53M |
| 451 | STLN | Starling Oncology, Inc. | 668.57M | 4.13% | 1,219,098 | 587.24M |
| 452 | CRMD | CorMedix Inc. | 653.95M | -1.99% | 865,512 | 462.25M |
| 453 | EIKN | Eikon Therapeutics, Inc. | 648.90M | -4.54% | 322,769 | - |
| 454 | ANGO | AngioDynamics, Inc. | 648.51M | -1.63% | 242,399 | 320.17M |
| 455 | MDXG | MiMedx Group, Inc. | 644.26M | 1.84% | 710,950 | 355.17M |
| 456 | CTNM | Contineum Therapeutics, Inc. | 640.31M | -0.18% | 387,857 | - |
| 457 | PRME | Prime Medicine, Inc. | 636.90M | -3.50% | 1,951,665 | 4.07M |
| 458 | CTEV | Claritev Corporation | 636.72M | -0.19% | 63,913 | 994.67M |
| 459 | TLRY | Tilray Brands, Inc. | 629.25M | -4.92% | 4,157,280 | 915.45M |
| 460 | VALN | Valneva SE | 627.52M | -1.25% | 28,237 | 163.30M |
| 461 | KIDS | OrthoPediatrics Corp. | 627.42M | -1.92% | 169,555 | 252.72M |
| 462 | AUTL | Autolus Therapeutics plc | 620.16M | -4.51% | 1,433,284 | 117.39M |
| 463 | RGNX | REGENXBIO Inc. | 619.20M | 5.27% | 1,157,979 | 174.48M |
| 464 | ALT | Altimmune, Inc. | 612.73M | -1.56% | 4,050,554 | 31.00K |
| 465 | ARVN | Arvinas, Inc. | 609.40M | -2.92% | 532,421 | 316.70M |
| 466 | SPRY | ARS Pharmaceuticals, Inc. | 599.67M | 5.42% | 1,163,506 | 116.93M |
| 467 | SCTX | Scribe Therapeutics Inc. | 598.00M | 1.57% | 245,107 | 36.28M |
| 468 | CTKB | Cytek Biosciences, Inc. | 594.02M | -0.22% | 437,687 | 206.71M |
| 469 | WEAV | Weave Communications, Inc. | 584.79M | 0.27% | 4,341,823 | 257.79M |
| 470 | EOLS | Evolus, Inc. | 579.92M | -2.23% | 1,513,608 | 316.49M |
| 471 | ARTV | Artiva Biotherapeutics, Inc. | 575.44M | - | 262,317 | 251.00K |
| 472 | ZURA | Zura Bio Limited | 574.02M | -5.22% | 1,802,093 | - |
| 473 | BWAY | BrainsWay Ltd. | 573.33M | -0.90% | 74,119 | 60.70M |
| 474 | DCTH | Delcath Systems, Inc. | 569.06M | -3.07% | 367,175 | 95.42M |
| 475 | BLSM | BlossomHill Therapeutics, Inc. | 565.68M | 0.22% | 55,698 | - |
| 476 | OVID | Ovid Therapeutics Inc. | 562.46M | -1.03% | 1,143,445 | 1.58M |
| 477 | EVH | Evolent Health, Inc. | 556.25M | 0.61% | 2,231,978 | 2.10B |
| 478 | ENTX | Entera Bio Ltd. | 552.32M | -8.07% | 523,310 | 42.00K |
| 479 | CERS | Cerus Corporation | 552.18M | 0.74% | 1,103,080 | 221.55M |
| 480 | CABA | Cabaletta Bio, Inc. | 551.02M | 0.93% | 2,486,357 | - |
| 481 | FLGT | Fulgent Genetics, Inc. | 545.08M | -0.70% | 170,750 | 323.93M |
| 482 | CAPR | Capricor Therapeutics, Inc. | 544.18M | 12.91% | 12,037,061 | 11.13M |
| 483 | SRTA | Strata Critical Medical, Inc. | 541.42M | -1.13% | 431,466 | 255.98M |
| 484 | TCMD | Tactile Systems Technology, Inc. | 532.56M | -0.30% | 206,804 | 350.31M |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 532.47M | -2.60% | 413,774 | - |
| 486 | RZLT | Rezolute, Inc. | 526.51M | 0.60% | 1,367,982 | - |
| 487 | PROK | ProKidney Corp. | 526.04M | 0.58% | 568,462 | 818.00K |
| 488 | CCCC | C4 Therapeutics, Inc. | 521.63M | 0.95% | 1,862,310 | 35.04M |
| 489 | EVMN | Evommune, Inc. | 512.08M | 2.32% | 343,008 | 10.00M |
| 490 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 491 | NPCE | NeuroPace, Inc. | 503.88M | 3.67% | 172,767 | 106.99M |
| 492 | CLPT | ClearPoint Neuro, Inc. | 499.35M | -3.48% | 505,992 | 42.28M |
| 493 | SENS | Senseonics Holdings, Inc. | 493.84M | -1.89% | 440,533 | 48.55M |
| 494 | KMDA | Kamada Ltd. | 490.45M | -2.90% | 306,129 | 191.85M |
| 495 | EDIT | Editas Medicine, Inc. | 488.38M | -3.05% | 2,947,996 | 47.01M |
| 496 | EPRX | Eupraxia Pharmaceuticals Inc. | 487.92M | 0.13% | 235,390 | - |
| 497 | DNA | Ginkgo Bioworks Holdings, Inc. | 486.87M | -4.11% | 628,755 | 132.42M |
| 498 | NRC | NRC Health | 486.63M | -0.09% | 125,763 | 140.00M |
| 499 | RLMD | Relmada Therapeutics, Inc. | 485.35M | -0.87% | 476,693 | - |
| 500 | PACB | Pacific Biosciences of California, Inc. | 484.90M | 2.63% | 7,848,444 | 159.27M |